Advanced search
Publication Cover
OncoImmunology Volume 8, 2019 - Issue 10
Submit an article Journal homepage
904
Views
0
CrossRef citations to date
0
Altmetric
Author's View

Tumor-binding antibodies induce potent dendritic cell-mediated tumor immunity

Yaron CarmiSchool of Medicine, Department of Pathology, Stanford University, Palo Alto, CA, USA
,
Tyler PrestwoodSchool of Medicine, Department of Pathology, Stanford University, Palo Alto, CA, USA
&
Edgar G. EnglemanSchool of Medicine, Department of Pathology, Stanford University, Palo Alto, CA, USACorrespondence[email protected] [email protected]
Article: e1078063 | Received 24 Jul 2015, Accepted 24 Jul 2015, Published online: 07 May 2018

References

  • Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 2013; 339:286–91; PMID:23329041; http://dx.doi.org/10.1126/science.1232227
  • Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011; 29:235–71; PMID:21219185; http://dx.doi.org/10.1146/annurev-immunol-031210-101324
  • Carmi Y, Spitzer MH, Linde IL, Burt BM, Prestwood TR, Perlman N, Davidson MG, Kenkel JA, Segal E, Pusapati GV et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature 2015; 521:99–104; PMID:25924063; http://dx.doi.org/10.1038/nature14424
  • Palucka K, Banchereau J. Dendritic-cell-based therapeutic cancer vaccines. Immunity 2013; 39:38–48; PMID:23890062; http://dx.doi.org/10.1016/j.immuni.2013.07.004
  • Fong L, Engleman EG. Dendritic cells in cancer immunotherapy. Ann Rev Immunol 2000; 18:245–73; PMID:10837059; http://dx.doi.org/10.1146/annurev.immunol.18.1.245
  • Soussi T. p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res 2000; 60:1777–88; PMID:10766157
  • Qin Z, Richter G, Schuler T, Ibe S, Cao X, Blankenstein T. B cells inhibit induction of T cell-dependent tumor immunity. Nat Med 1998; 4:627–30; PMID:9585241; http://dx.doi.org/10.1038/nm0598-627
  • Gerber JS, Mosser DM. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. J Immunol 2001; 166:6861–8; PMID:1359846; http://dx.doi.org/10.4049/jimmunol.166.11.6861
  • Andreu P, Johansson M, Affara NI, Pucci F, Tan T, Junankar S, Korets L, Lam J, Tawfik D, DeNardo DG et al. FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 2010; 17:121–34; PMID:20138013; http://dx.doi.org/10.1016/j.ccr.2009.12.019
  • Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008; 8:34–47; PMID:18064051; http://dx.doi.org/10.1038/nri2206

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.